Infinity Pharmaceuticals, Inc.
Heterocyclic compounds and uses thereof

Last updated:

Abstract:

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Status:
Grant
Type:

Utility

Filling date:

7 Jun 2017

Issue date:

16 Feb 2021